NASDAQ:TSHA | Income Statement | Taysha Gene Therapies, Inc.

Complete source-backed income-statement history.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$0.00$38.64M$47.35M-$47.35M$710,000.00-$46.64M-$0.13-$0.13369,044,040369,044,040
2026-03-31$0.00$33.81M$43.49M-$43.49M$1.08M$0.00-$42.41M-$0.12-$0.12366,632,827366,632,827
2025-12-31$5.49M$24.95M$33.79M-$28.3M$449,000.00$0.00-$27.85M-$0.08-$0.0812,535,99012,535,990
2025-09-30$0.00$25.75M$34.02M-$34.02M$1.29M-$32.73M-$0.09-$0.09353,309,524353,309,524
2025-06-30$1.99M$20.14M$28.74M-$26.75M-$129,000.00-$26.88M-$0.09-$0.09297,988,978297,988,978
2025-03-31$2.3M$15.57M$23.72M-$21.42M-$108,000.00$0.00-$21.53M-$0.08-$0.08269,306,331269,306,331
2024-12-31$2.02M$15.33M$21.95M-$19.93M$1.15M$0.00-$18.79M-$0.07-$0.076,082,3646,082,364
2024-09-30$1.79M$14.95M$27.69M-$25.9M$374,000.00-$25.52M-$0.10-$0.10267,824,045267,824,045
2024-06-30$1.11M$15.07M$22.41M-$21.3M$371,000.00-$20.93M-$0.09-$0.09232,821,553232,821,553
2024-03-31$3.41M$20.66M$27.74M-$24.33M$269,000.00$0.00-$24.06M-$0.10-$0.10231,249,344231,249,344
2023-12-31$3.6M$12.68M$19.85M-$16.25M$63.99M$0.00$47.74M$0.92$0.9231,490,68631,490,686
2023-09-30$4.75M$11.79M$21M-$16.25M-$100.84M-$117.09M-$0.93-$0.93125,700,799125,700,799
2023-06-30$2.4M$19.79M$25.78M-$23.38M-$1.21M-$24.6M-$0.38-$0.3864,244,53164,244,531
2023-03-31$4.71M$12.51M$21.27M-$16.56M-$1.06M$0.00-$17.62M-$0.28-$0.2863,260,90563,260,905
2022-12-31$12.71M$56.47M-$53.97M-$1.11M$0.00-$55.08M-$0.99-$0.994,190,2514,190,251
2022-09-30$16.77M$25.46M-$25.46M-$1.07M-$26.53M-$0.65-$0.6540,937,80840,937,808
2022-06-30$23.51M$33.37M-$33.37M-$719,000.00-$34.09M-$0.85-$0.8540,142,40340,142,403
2022-03-31$38.18M$49.65M-$49.65M-$666,000.00$0.00-$50.32M-$1.32-$1.3238,174,71738,174,717
2021-12-31$37.92M$49.72M-$49.72M-$662,000.00-$50.39M-$1.33-$1.33155,029155,029
2021-09-30$39.53M$50.68M-$50.68M-$506,000.00-$51.19M-$1.35-$1.3538,003,95438,003,954
2021-06-30$30.64M$40.77M-$40.77M-$154,000.00-$40.93M-$1.09-$1.0937,479,16437,479,164
2021-03-31$23.85M$32.09M-$32.09M$66,000.00$0.00-$32.02M36,992,377
2020-12-31$12.26M$18.37M-$18.37M$49,000.00-$18.32M6,489,254
2020-09-30$11.06M$15.04M-$15.04M-$1,000.00-$15.04M11,733,170
2020-06-30$3.06M$4.01M-$4.01M-$17.21M-$21.22M10,894,999
2020-03-31$5.51M$5.58M-$5.58M$153,000.00-$5.43M10,894,999

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31$9.77M$86.4M$120.27M-$110.5M$1.5M$0.00-$109M-$0.34-$0.34319,711,972319,711,972
2024-12-31$8.33M$66M$99.79M-$91.46M$2.16M$0.00-$89.3M-$0.36-$0.36250,134,421250,134,421
2023-12-31$15.45M$56.78M$87.89M-$72.44M-$39.13M$0.00-$111.57M-$0.96-$0.96116,121,482116,121,482
2022-12-31$2.5M$91.17M$164.95M-$162.45M-$3.57M$0.00-$166.01M-$3.78-$3.7843,952,01543,952,015
2021-12-31$131.94M$173.27M-$173.27M-$1.26M-$174.52M-$4.64-$4.6437,650,56637,650,566
2020-12-31$31.89M$43M-$43M-$17.01M$0.00-$60.01M17,665,683

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.